EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts

Tim E Moors, Dragomir Milovanovic

Journal of Parkinson’s Disease · 23.01.2024 · 14 (1) · 17-33

DOI: 10.3233/jpd-230183 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Parkinson’s Disease, online erschienen am 04.01.2024. Verfasst von Tim E Moors und 1 weiteren Autor:innen. Beteiligte Einrichtung: Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies, Running, Lewy Body Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lewy bodies (LBs) are pathological hallmarks of Parkinson’s disease and dementia with Lewy bodies, characterized by the accumulation of α-synuclein (αSyn) protein in the brain. While LBs were first described a century ago, their formation and morphogenesis mechanisms remain incompletely understood. Here, we present a historical overview of LB definitions and highlight the importance of semantic clarity and precise definitions when describing brain inclusions. Recent breakthroughs in imaging revealed shared features within LB subsets and the enrichment of membrane-bound organelles in these structures, challenging the conventional LB formation model. We discuss the involvement of emerging concepts of liquid-liquid phase separation, where biomolecules demix from a solution to form dense condensates, as a potential LB formation mechanism. Finally, we emphasize the need for the operational definitions of LBs based on morphological characteristics and detection protocols, particularly in studies investigating LB formation mechanisms. A better understanding of LB organization and ultrastructure can contribute to the development of targeted therapeutic strategies for synucleinopathies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseSynucleinopathiesRunningLewy Body DiseaseHumansLewy Bodiesalpha-SynucleinBrain

Stichwörter der Autor:innen

Lewy bodyParkinson’s diseaseaggregationliquid-liquid phase separationα-synuclein

Substanzen

alpha-Synuclein

Autor:innen und Institutionen

  • Ann Romney Center for Neurologic Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Laboratory of Molecular Neuroscience, German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
  • Einstein Center for Neuroscience, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität Berlin, and Berlin Institute of Health, Berlin, Germany.

Zitieren

APA

Moors, T. E., & Milovanovic, D. (2024). Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts. Journal of Parkinson’s Disease, 14(1), 17-33. https://doi.org/10.3233/jpd-230183

Vancouver

Moors TE, Milovanovic D. Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts. Journal of Parkinson’s Disease. 2024;14(1):17-33. doi:10.3233/jpd-230183

BibTeX
@article{Moors2024,
  author = {Moors, Tim E and Milovanovic, Dragomir},
  title = {Defining a Lewy Body: Running Up the Hill of Shifting Definitions and Evolving Concepts},
  journal = {Journal of Parkinson’s Disease},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {17--33},
  doi = {10.3233/jpd-230183}
}
Kostenlos starten →